# Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

> **NCT01475643** · PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 107 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Loteprednol etabonate
- **DRUG:** Prednisolones acetate

## Key facts

- **NCT ID:** NCT01475643
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2017-06-02
- **Final completion:** 2017-07
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2019-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475643, "Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01475643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*